Effect of diltiazem and verapamil on endothelin release by cultured human coronary smooth-muscle cells and endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Haug, Cornelia ^a   Voisard, Rainer ^a   Baur, Regine ^a   Hannekum, Andreas ^a   Hombach, Vinzenz ^a   Gruenert, Adolf ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Calcium channel antagonists; Coronary endothelial cells; Coronary smooth muscle cells; Endothelin

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIN; VERAPAMIL;

AGED; ARTICLE; CELL CULTURE; CHEMICAL PHENOMENA; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG EFFECT; HUMAN; METABOLISM; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

AGED; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CORONARY DISEASE; CORONARY VESSELS; DEPRESSION, CHEMICAL; DILTIAZEM; ENDOTHELINS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; VERAPAMIL;

EID: 0031618358     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00111     Document Type: Article

References (13)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-52.
3. Resink TJ, Hahn AWA, Scott-Burden T, Powell J, Weber E, Bühler FR. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 1990;168:1303-10.
4. Zeiher AM, Goebel H, Schächinger V, Ihling C. Tissue endothelin-I immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995;91:941-7.
5. Haug C, Voisard R, Lenich A, et al. Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries. Cardiovasc Res 1996;31:807-13.
6. Blumlein SL, Sievers R, Kidd P, Parmley WW. Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit. Am J Cardiol 1984;54:884-9.
7. 2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits. Angiology 1984;35: 622-7.
8. Sugano M, Nakashima Y, Matsushima T, et al. Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection. Arteriosclerosis 1986;6:237-41.
9. Timm M, Kaski JC, Dashwood MR. Endothelin-like immunoreactivity in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 1995;26(suppl 3):S442-4.
10. Opgaard OS, Adner M, Gulbenkian S, Edvinsson L. Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 1994;23:576-83.
11. Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem 1994; 269:10112-8.
12. Jackson CL, Bush RC, Bowyer DE. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis 1988;69:115-22.
13. Hoberg E, Dietz R, Frees U, et al. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J 1994;71:254-60.